Ashima Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 23, 2025, 8:29 am

Quick Insight

Ashima Ltd, operating in the textiles-spinning-cotton blended industry, currently trades at a price of 24.6, with a market capitalization of 470 Cr. The company's financial indicators reveal challenges, with a negative operating profit margin of -147.30%, a net profit of -19 Cr, and an interest coverage ratio of -1.98x. Despite these struggles, Ashima Ltd boasts a healthy promoter holding of 73.49% and reserves of 107 Cr. However, the lack of FII and DII investments indicates a potential lack of confidence from institutional investors. With a low ROE of 5.75% and ROCE of 1.83%, Ashima Ltd faces hurdles in generating returns for its shareholders. In conclusion, while the company shows resilience in promoter support and reserves, it must address its profitability and investor confidence to drive sustainable growth in the future.

Competitors of Ashima Ltd

All Competitor Stocks of Ashima Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:30 pm

Below is a detailed analysis of the quarterly data for Ashima Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2.44 Cr.. The value appears strong and on an upward trend. It has increased from 0.74 Cr. (Mar 2025) to 2.44 Cr., marking an increase of 1.70 Cr..
• For Expenses, as of Jun 2025, the value is 2.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.83 Cr. (Mar 2025) to 2.67 Cr., marking an increase of 0.84 Cr..
• For Operating Profit, as of Jun 2025, the value is -0.23 Cr.. The value appears strong and on an upward trend. It has increased from -1.09 Cr. (Mar 2025) to -0.23 Cr., marking an increase of 0.86 Cr..
• For OPM %, as of Jun 2025, the value is -9.43%. The value appears strong and on an upward trend. It has increased from -147.30% (Mar 2025) to -9.43%, marking an increase of 137.87%.
• For Other Income, as of Jun 2025, the value is -0.79 Cr.. The value appears to be declining and may need further review. It has decreased from 6.09 Cr. (Mar 2025) to -0.79 Cr., marking a decrease of 6.88 Cr..
• For Interest, as of Jun 2025, the value is 1.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.68 Cr. (Mar 2025) to 1.72 Cr., marking an increase of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 0.07 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.07 Cr..
• For Profit before tax, as of Jun 2025, the value is -2.81 Cr.. The value appears to be declining and may need further review. It has decreased from 3.25 Cr. (Mar 2025) to -2.81 Cr., marking a decrease of 6.06 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -2.81 Cr.. The value appears to be declining and may need further review. It has decreased from 3.25 Cr. (Mar 2025) to -2.81 Cr., marking a decrease of 6.06 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.15. The value appears to be declining and may need further review. It has decreased from 0.17 (Mar 2025) to -0.15, marking a decrease of 0.32.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:24 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 3:34 pm

Below is a detailed analysis of the balance sheet data for Ashima Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 192.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 192.00 Cr..
• For Reserves, as of Mar 2025, the value is 107.00 Cr.. The value appears to be declining and may need further review. It has decreased from 125.00 Cr. (Mar 2024) to 107.00 Cr., marking a decrease of 18.00 Cr..
• For Borrowings, as of Mar 2025, the value is 122.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 124.00 Cr. (Mar 2024) to 122.00 Cr., marking a decrease of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 82.00 Cr.. The value appears to be improving (decreasing). It has decreased from 92.00 Cr. (Mar 2024) to 82.00 Cr., marking a decrease of 10.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 502.00 Cr.. The value appears to be improving (decreasing). It has decreased from 533.00 Cr. (Mar 2024) to 502.00 Cr., marking a decrease of 31.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 131.00 Cr. (Mar 2024) to 47.00 Cr., marking a decrease of 84.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 7.00 Cr..
• For Investments, as of Mar 2025, the value is 37.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 37.00 Cr., marking an increase of 6.00 Cr..
• For Other Assets, as of Mar 2025, the value is 419.00 Cr.. The value appears strong and on an upward trend. It has increased from 364.00 Cr. (Mar 2024) to 419.00 Cr., marking an increase of 55.00 Cr..
• For Total Assets, as of Mar 2025, the value is 502.00 Cr.. The value appears to be declining and may need further review. It has decreased from 533.00 Cr. (Mar 2024) to 502.00 Cr., marking a decrease of 31.00 Cr..

However, the Borrowings (122.00 Cr.) are higher than the Reserves (107.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Ashima Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 22, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 22, the value is 0.93. This value is below the healthy minimum of 5. It has increased from -0.60 (Mar 21) to 0.93, marking an increase of 1.53.
• For Diluted EPS (Rs.), as of Mar 22, the value is 0.93. This value is below the healthy minimum of 5. It has increased from -0.60 (Mar 21) to 0.93, marking an increase of 1.53.
• For Cash EPS (Rs.), as of Mar 22, the value is 1.10. This value is below the healthy minimum of 3. It has increased from -0.37 (Mar 21) to 1.10, marking an increase of 1.47.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 11.80. It has increased from 10.91 (Mar 21) to 11.80, marking an increase of 0.89.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 11.80. It has increased from 10.91 (Mar 21) to 11.80, marking an increase of 0.89.
• For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 10.82. It has increased from 7.38 (Mar 21) to 10.82, marking an increase of 3.44.
• For PBDIT / Share (Rs.), as of Mar 22, the value is -0.23. This value is below the healthy minimum of 2. It has decreased from -0.19 (Mar 21) to -0.23, marking a decrease of 0.04.
• For PBIT / Share (Rs.), as of Mar 22, the value is -0.39. This value is below the healthy minimum of 0. It has increased from -0.43 (Mar 21) to -0.39, marking an increase of 0.04.
• For PBT / Share (Rs.), as of Mar 22, the value is 1.35. This value is within the healthy range. It has increased from -0.60 (Mar 21) to 1.35, marking an increase of 1.95.
• For Net Profit / Share (Rs.), as of Mar 22, the value is 0.93. This value is below the healthy minimum of 2. It has increased from -0.61 (Mar 21) to 0.93, marking an increase of 1.54.
• For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is 0.93. This value is below the healthy minimum of 2. It has increased from -0.59 (Mar 21) to 0.93, marking an increase of 1.52.
• For PBDIT Margin (%), as of Mar 22, the value is -2.18. This value is below the healthy minimum of 10. It has increased from -2.67 (Mar 21) to -2.18, marking an increase of 0.49.
• For PBIT Margin (%), as of Mar 22, the value is -3.68. This value is below the healthy minimum of 10. It has increased from -5.95 (Mar 21) to -3.68, marking an increase of 2.27.
• For PBT Margin (%), as of Mar 22, the value is 12.46. This value is within the healthy range. It has increased from -8.19 (Mar 21) to 12.46, marking an increase of 20.65.
• For Net Profit Margin (%), as of Mar 22, the value is 8.64. This value is within the healthy range. It has increased from -8.31 (Mar 21) to 8.64, marking an increase of 16.95.
• For NP After MI And SOA Margin (%), as of Mar 22, the value is 8.64. This value is within the healthy range. It has increased from -8.10 (Mar 21) to 8.64, marking an increase of 16.74.
• For Return on Networth / Equity (%), as of Mar 22, the value is 7.92. This value is below the healthy minimum of 15. It has increased from -5.48 (Mar 21) to 7.92, marking an increase of 13.40.
• For Return on Capital Employeed (%), as of Mar 22, the value is -3.17. This value is below the healthy minimum of 10. It has increased from -3.68 (Mar 21) to -3.17, marking an increase of 0.51.
• For Return On Assets (%), as of Mar 22, the value is 5.64. This value is within the healthy range. It has increased from -4.26 (Mar 21) to 5.64, marking an increase of 9.90.
• For Long Term Debt / Equity (X), as of Mar 22, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 21) to 0.03, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 22, the value is 0.04. This value is within the healthy range. It has decreased from 0.05 (Mar 21) to 0.04, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 22, the value is 0.70. It has increased from 0.50 (Mar 21) to 0.70, marking an increase of 0.20.
• For Current Ratio (X), as of Mar 22, the value is 2.29. This value is within the healthy range. It has decreased from 3.04 (Mar 21) to 2.29, marking a decrease of 0.75.
• For Quick Ratio (X), as of Mar 22, the value is 1.28. This value is within the healthy range. It has decreased from 2.14 (Mar 21) to 1.28, marking a decrease of 0.86.
• For Inventory Turnover Ratio (X), as of Mar 22, the value is 2.39. This value is below the healthy minimum of 4. It has increased from 1.24 (Mar 21) to 2.39, marking an increase of 1.15.
• For Interest Coverage Ratio (X), as of Mar 22, the value is -1.98. This value is below the healthy minimum of 3. It has decreased from -1.20 (Mar 21) to -1.98, marking a decrease of 0.78.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is -3.34. This value is below the healthy minimum of 3. It has decreased from -2.71 (Mar 21) to -3.34, marking a decrease of 0.63.
• For Enterprise Value (Cr.), as of Mar 22, the value is 261.65. It has decreased from 269.33 (Mar 21) to 261.65, marking a decrease of 7.68.
• For EV / Net Operating Revenue (X), as of Mar 22, the value is 1.26. This value is within the healthy range. It has decreased from 1.90 (Mar 21) to 1.26, marking a decrease of 0.64.
• For EV / EBITDA (X), as of Mar 22, the value is -57.63. This value is below the healthy minimum of 5. It has increased from -71.06 (Mar 21) to -57.63, marking an increase of 13.43.
• For MarketCap / Net Operating Revenue (X), as of Mar 22, the value is 1.30. This value is within the healthy range. It has decreased from 2.15 (Mar 21) to 1.30, marking a decrease of 0.85.
• For Price / BV (X), as of Mar 22, the value is 1.20. This value is within the healthy range. It has decreased from 1.45 (Mar 21) to 1.20, marking a decrease of 0.25.
• For Price / Net Operating Revenue (X), as of Mar 22, the value is 1.31. This value is within the healthy range. It has decreased from 2.15 (Mar 21) to 1.31, marking a decrease of 0.84.
• For EarningsYield, as of Mar 22, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.03 (Mar 21) to 0.06, marking an increase of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness